Prescription portability between countries

Prescription portability between countries — setting out what I have, and where I think it stops being reliable.

Asking about prescription portability between countries directly, because I have read four threads on it and each answered a slightly different question.

The version I want answered is the narrow one: given the method stated below, is the result within what anyone else has seen? I am not asking what it means yet.

Method, numbers and the two assumptions I am aware of making are below. If the assumptions are wrong that is more useful to me than agreement.

I keep a log for prescription portability between countries specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.

Post #2 answers the question as asked. The question underneath it is different.

Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is unclear.

I read post #4 twice before replying, because I had assumed the opposite.

Where I have landed on prescription portability between countries, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it from somewhere that did not measure it.

Reading rather than contributing, but this is the most useful thread I have found on it.

Adding the boring version of prescription portability between countries, because the interesting version keeps getting posted and the boring one is usually right.

Check the ordinary explanations, in order, and stop when one of them accounts for what you are seeing. Most of the time the second one does.

Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more predictive than theory.

Right — I had this wrong and I am glad to have read it before it mattered.

Picking up post #7: that is the part I would want checked first.

The useful distinction on prescription portability between countries is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.

A note on how prescription portability between countries gets discussed rather than on prescription portability between countries itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been right more often.

Coming back to post #10, because the follow-up matters more than the original answer.

Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not eliminate) risk.

Worth saying I have only my own numbers here, and n is small.

Post #12 answers the question as asked. The question underneath it is different.

I read the earlier replies on prescription portability between countries twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than what I expected.

Sensible. I would want the same detail before I acted on it either.